ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    The Coefficient of Variability of Tacrolimus Levels Can Predict Antibody-Mediated Rejection After Renal Transplantation.

    P. Ruiz-Esteban,1 M. Gonzalez-Molina,1 A. Caballero,2 E. Palma,1 D. Burgos,1 M. Cabello,1 J. Alonso-Titos,1 A. Duarte,1 D. Hernandez.1

    1Nephrology, Regional Universitary Hospital, IBIMA, University of Malaga, Malaga, Spain; 2Immunology, Regional University Hospital, IBIMA, University of Malaga, Malaga, Spain.

    Introduction. Antibody-mediated rejection (ABMR) is the major cause of allograft failure. We studied whether the coefficient of variability (CV) of blood levels of tacrolimus can…
  • 2016 American Transplant Congress

    Induction Agent Use and Outcomes in Older KT Recipients: Patient and Center Level Associations.

    M. McAdams-DeMarco, Q. Huang, X. Luo, B. Orandi, S. Dorry.

    Johns Hopkins, Baltimore.

    Background: Clinical trials of induction agents typically exclude older recipients, so our practice in older recipients is extrapolated from this. Older adults are different, so…
  • 2016 American Transplant Congress

    Impact of the New Kidney Allocation System on Highly Sensitized Patients: Single Center Report.

    A. Mattiazzi,1 W. Kupin,1 D. Roth,1 L. Chen,2 G. Burke,2 G. Ciancio,2 P. Ruiz,2 R. Vianna,2 G. Guerra.1

    1Department of Medicine, Division of Nephrology, Miami Transplant Institute, Miami, FL; 2Department of Surgery, Miami Transplant Institute, Miami, FL.

    Background: Highly sensitized patients (HSP) with calculated Panel Reactive Antibody (cPRA) >80% are known to have extensive waiting time on UNOS list. The new kidney…
  • 2016 American Transplant Congress

    The Simplified EPTS Score: Who Wins and Who Loses?

    J. Schold, E. Poggio, R. Fatica, S. Flechner, L. Buccini, D. Goldfarb.

    Cleveland Clinic, Cleveland, OH.

    The New Kidney Allocation System includes provisions that candidates with EPTS score in the lowest 20% (indicating best expected survival) have access to the highest…
  • 2016 American Transplant Congress

    Activating Transcription Factor 5 (ATF5) Regulates Liver Ischemia/Reperfusion Injury.

    G.-Q. Shen,2 M. Morita,1 J. Fung,2 L. Lu,1,2 S. Qian.1,2

    1Immunology, LernerResearch Institute, Cleveland Clinic, Cleveland, OH; 2General Surgery, Transplant Center, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH.

    Activating transcription factor 5 (ATF5), a member of the ATF/cAMP response element-binding proteins, is extremely highly expressed in the liver, the significance of which is…
  • 2016 American Transplant Congress

    Activation of Innate Immunity During Human OLT-IRI Triggers Adaptive Immunity and Correlates with the Degree of IRI Injury.

    A. Zarrinpar,1 R. Sosa,2 P. Rao,2 C. Lassman,2 R. Busuttil,1 D. Gjertson,2 J. Kupiec-Weglinski,1 E. Reed.2

    1Surgery, Dumont-UCLA Transplant Ctr, Los Angeles, CA; 2Pathology, UCLA, Los Angeles, CA.

    Ischemia reperfusion injury (IRI) in orthotopic liver transplantation (OLT) can severely compromise graft and recipient survival. We postulate this is mediated by interactions between the…
  • 2016 American Transplant Congress

    The Impact of Pre-Donation eGFR on Recipient Outcomes, as a Function of Donor Age.

    J. Gill,1 J. Dong,2 O. Djurdjev,2 J. Lesage,1 C. Rose,1 J. Gill.1

    1Medicine, UBC, Vancouver, BC, Canada; 2BC Renal Agency, Vancouver, BC, Canada.

    Transplantation from older living kidney donors is increasing. Studies have shown that living donor age only modestly impacts recipient outcomes, but the kidney function of…
  • 2016 American Transplant Congress

    Can Qrisk Be Useful to Predict Future Cardiovascular Co-Morbidites and Type II Diabetes in Living Kidney Donors Prior to Donation?

    S. Bhutani, R. Chinnadurai, G. Bernal-Blanco, B. Patel, A. Summers, D. Van Dellen, M. Morton, P. Michael.

    Department of Renal & Transplant Medicine, Manchester Royal Infirmary, Manchester, United Kingdom.

    Introduction:Living kidney donor transplantation has demonstrated significant survival benefits to individuals with End Stage Renal Disease (ESRD). However, The long term cardiovascular risks associated with…
  • 2016 American Transplant Congress

    Urinary Neutrophil Gelatinase-Associated Lipocalin in Living Kidney Donor Nephrectomy.

    Y. Yoon,1 H. Lee,1 D. Joo,2 K. Huh,2 M. Kim,2 S. Kim,2 Y. Kim,2 W. Han.1

    1Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; 2Transplantation Surgery, Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Republic of Korea.

    Introduction: Urinary neutrophil gelatinase-associated lipocalin (uNGAL) is a marker for acute kidney injury. This study was conducted to evaluate the efficacy of perioperative uNGAL in…
  • 2016 American Transplant Congress

    Controlled Cardiac Death Donor Program for Kidney Transplantation – Spanish Multicenter Experience with Two Years of Follow-Up.

    J. Portoles,1 M. Perez-Saez,2 D. Hernandez-Marrero,2 O. Lafuente,1 F. Diekmann,2 N. Maruri Kareaga,2 M. Rodriguez-Ferrero,2 F. Llamas,2 M. Mazuecos,2 J. Juega,2 E. Melilli,2 A. Rodriguez-Benot,2 A. Alonso,2 J. Pascual.2

    1Nephrology, U.H.Puerta de Hierro-RedinRen, Majadahonda, Spain; 2Nephrology, SENTRA-GEODAS Group, Madrid, Spain.

    Background: Controlled donation after cardiac death (cDCD) programs are running in several countries for years. National transplant organization (ONT) has developed a nation-wide program in…
  • « Previous Page
  • 1
  • …
  • 105
  • 106
  • 107
  • 108
  • 109
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences